Objectives. To evaluate feeding tube utilization in patients with salivary gland malignancies (SGMs).
S alivary gland malignancies (SGMs) represent a rare and heterogeneous group of tumors composing approximately 3% to 6% of head and neck cancers in the United States. 1, 2 Predominant histopathologies include mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinoma, and acinic cell carcinoma, among others. These tumors most commonly arise in the major glands (parotid, submandibular, and sublingual) but can occur in mucosal surfaces, such as the sinonasal tract and oropharynx. While primary intervention is traditionally surgery, modern advances in diagnostic and therapeutic technologies have increased the role of radiotherapy and chemotherapy. Adjuvant radiation after primary surgical resection and concurrent chemoradiotherapy are associated with greater locoregional and distant control of disease with adverse pathologic features. [3] [4] [5] Five-year survival rates of SGMs reported in recent decades range from 51% to 94%, depending on tumor burden and stage. 3, 4, [6] [7] [8] Favorable survival probabilities merit attention to toxicity profiles and quality of life after SGM. Swallowing-related issues remain prominent in general head and neck cancer survivorship, with gastrostomy utilization upward of 50% in patients treated with radiotherapy for mucosal primary tumors of the head and neck region. 9 Treatment-related side effects such as dysphagia, odynophagia, xerostomia, and mucositis predispose patients to malnutrition, weight loss, poor wound healing, and prolonged recovery. Overall, the need for enteral feeding serves as a surrogate marker for acute treatment-related toxicity at times when patients exhibit impaired oral intake, weight loss, dysphagia, and risk for aspiration.
Long-term gastrostomy dependence is thought to reflect chronic swallowing dysfunction, and rates are dependent on site, stage, and treatment parameters. Gastrostomy tube (G-tube) dependence is commonly reported as a measure of functional outcome for patients with carcinomas of the head and neck. [10] [11] [12] Historically, studies analyzing nutrition outcomes typically combine multiple subgroups of head and neck cancer. 12 Prior site-specific investigations of G-tube utilization from our group have identified factors affecting feeding tube timing and dependence, such as type of radiotherapy and concomitant boost fractionation schedules. 9, 13 To date, no studies have focused on feeding tube usage in patients with salivary gland cancers, and the heterogeneity of SGMs presents a challenge to recognizing factors affecting enteral support. Greater understanding of functional outcomes specific to SGM will help identify SGM subgroups at high risk for G-tube placement and address patient expectations in this cohort. Therefore, this study serves to characterize feeding tube utilization and dependence among patients with SGMs.
Methods

Study Design and Eligibility
Patients with newly diagnosed SGMs and no prior history of cancer (with the exception of nonmelanoma skin cancer) were prospectively recruited to an epidemiologic cohort at The University of Texas MD Anderson Cancer Center between 2001 and 2013. The study cohort was approved by the MD Anderson Cancer Center Institutional Review Board, and each subject provided informed consent before being recruited. A total of 324 SGM patients were recruited to the cohort. A 12-year retrospective review was undertaken to investigate feeding tube utilization in patients with previously untreated SGMs sampled from the epidemiologic registry. Patients with lymphoproliferative malignancies were not included. Thirty-seven patients with outside locoregional therapy or palliative treatment were excluded. The remaining 287 patients from the SGM cohort who underwent primary locoregional therapy for curative intent at our institution were included in this study.
Data Collection
Data variables included demographics, pathology, treatment parameters, feeding tube characteristics, and clinical status at last follow-up visit. Type of radiation, dosage, and neck field, if any, were recorded as well as any chemotherapy agent and schedule. Surgical fields felt to reflect elevated risk of postoperative dysphagia were coded as any combination of oral cavity, pharynx, and larynx, based on structures resected.
Locations of SGMs were classified into 5 major subsites: oral, major gland, pharynx and larynx, sinonasal, and other. Oral cavity carcinomas included those of the buccal mucosa, floor of mouth, lip, mandibular and maxillary gingiva, retromolar trigone, hard palate, and oral tongue. Major gland carcinomas were tumors of the parotid, sublingual, and submandibular glands. Cancers of the pharynx and larynx arose from the base of tongue, soft palate, piriform sinus, and subglottis. Sinonasal tract cancers involved the ethmoid, maxilla, nose, nasopharynx, and nasal septum. Remaining tumors arising in the neck, thyroid, ear, lacrimal gland, parathyroids, and scapula were classified as other. Single-modality treatment was defined as surgery or radiation alone. A combination of surgery, radiation, and/or chemotherapy was considered multimodality treatment.
Speech pathology referrals were coded. Referrals to a speech pathologist for swallow assessment before treatment depended on primary site of cancer and surgeon's impression on dysphagia risk. Patients who underwent surgical resection of structures in the oral cavity or oropharynx also typically received postoperative inpatient swallow evaluation by speech pathology. These patients received swallowing exercises related to tongue base retraction, pharyngeal constriction, and laryngeal closure.
For surgical patients in the perioperative setting, feeding tubes were placed at the discretion of the surgeon based on perceived risk of dysphagia due to the extent of surgical resection or if recommended after postoperative swallow evaluation by the speech pathologist. Patients generally received a gastrostomy feeding tube if they demonstrated failure to convert to oral intake within 6 weeks of surgery or by the time that adjuvant therapy was initiated. For nonsurgical patients, feeding tubes were not placed prophylactically.
Feeding tube data included type, duration, and timing of placement. Feeding tubes utilized were nasogastric or Dobhoff tubes (nasogastric tube [NG-tube]) and percutaneous G-tube. Chronic G-tube dependence was defined as having the feeding tube at last follow-up visit. Patients who underwent removal of their G-tube were considered to have temporary G-tube dependence. Sources of chronic dependence were ascertained from patient history and coded as selfreported dysphagia, clinically documented aspiration, xerostomia, and dysgeusia.
Statistical Considerations
Primary clinical end points were incidence and duration of feeding tube usage. Associations between feeding tube outcomes and study variables were analyzed for statistical significance according to Pearson's chi-square and Fischer's exact tests. Multinomial ordered logistic regression analysis was performed to identify risk factors for feeding tube utilization. Feeding tube group (no tube, temporary nasogastric, temporary gastrostomy, chronic gastrostomy) was regressed on candidate predictors first in univariate models. The multivariate model was fit through stepwise backward elimination. The final model retained covariates that were independently associated with feeding tube utilization (P \ .05). A P value \.05 was considered statistically significant. Statistical analyses were performed through STATA data analysis software (version 14.0; StataCorp, College Station, Texas).
Results
Patient Characteristics
Of 324 patients with SGMs recruited to the parent prospective molecular epidemiologic study, 287 patients (54% female) met criteria for this study. Their median age was 55 years (interquartile range [IQR]: 45-65). The majority of cancers were adenoid cystic (37%) and mucoepidermoid carcinoma (22%), followed by acinic cell carcinoma (10%) and adenocarcinoma (9%). The most common location of these SGMs were major glands (41%), followed by oral cavity (29%), pharynx and larynx (13%), and sinonasal tract (13%). Additional demographics are detailed in Table 1 .
Treatment Characteristics and Follow-up
A total of 271 (94%) patients underwent surgical intervention, and 165 (57%) received adjuvant therapy with either radiotherapy (47%) or chemoradiation (10%). The remaining patients received primary nonsurgical therapy, including singlemodality radiation (1%) or chemoradiation (5%). Overall, a multimodality approach constituted 62% of treatment regimens. Table 2 provides further treatment information.
The majority of surgeries did not involve swallow-critical structures of the oral cavity, pharynx, or larynx (52%). Operations of the oral cavity composed 39% cases, while 8% of cases involved oral cavity and pharyngeal or laryngeal structures. For surgical reconstruction, 18% of patients received a free flap, and 6% received a local flap. For radiation therapy, the primary modality was intensity-modulated radiotherapy (82% of radiotherapy cohort). Only 34% of all patients received radiation to the neck.
Median follow-up time was 2.4 years (range: 41 days to 12.4 years). Almost 70% of the total SGM cohort had no evidence of disease at last clinic visit. Death attributable to disease and other causes occurred in 12% and 7% patients, respectively.
Feeding Tube Utilization
NG-tube placement was required for 79 of 287 (28%) patients during treatment of SGMs, with a median duration of 13 days (IQR: 6-21 days). Characteristics of feeding tube placement are summarized in Table 3 . Of those 79 patients, 30 (10% of total SGM cohort) required conversion to percutaneous gastrostomy. Median G-tube duration was 4.8 months (IQR: 3.7-13.1 months). Of the 30 patients, 21 had temporary G-tube placement, with median duration of 4.1 months (IQR: 3.1-6.2 months). Gastrostomy dependence over time is plotted in Figure 1 . While 9 patients (3% of total SGM cohort) were chronically gastrostomy dependent, 14% (3 of 22) of patients with pharyngeal and laryngeal SGM sites treated with multimodality therapy remained chronically G-tube dependent. Table 4 demonstrates feeding tube characteristics in association with study variables. Feeding tube utilization significantly differed by site of SGM (P \ .001). As stratified by tumor site, 28 of 36 (79%) patients with SGMs arising from the pharynx and larynx required a NG-tube, and 12 (31%) patients in this group underwent G-tube placement. The subgroup with the second-highest feeding tube rate was that with sinonasal tract tumors, as 11 of 37 (30%) patients needed an NG-tube and 6 (17%) required a G-tube. In all other sites, the proportion of patients requiring NG-tubes and G-tubes ranged from 13% to 28% and from 6% to 7%, respectively. Treatment modality was also significantly associated with feeding tube utilization. As stratified by treatment type, 35% (63 of 179) of patients treated with a multimodality regimen and 15% of patients with single-modality therapy required NG-tube (P \ .01). A G-tube was necessary only in patients receiving multimodality therapy (P \ .01). Among patients requiring multimodality therapy, 50% with SGMs arising from pharyngeal and laryngeal sites required G-tube placement, as compared with 8% to 19% of SGMs arising from all other sites (P \ .001). Figure 2 illustrates the distribution of feeding tube characteristics by site and treatment modality.
Factors Associated with Feeding Tube Utilization
Surgical and radiation characteristics were also significant predictors of feeding tube utilization. Oral cavity, pharyngeal, and/or laryngeal resection was significantly associated with both NG-tube (P \ .01) and G-tube (P = .02) placement. For patients who underwent reconstruction, 27% who received a free flap required G-tube placement, as compared with 6% of those with a local flap; furthermore, 6 (12%) patients with free flaps became chronically G-tube dependent, compared with 2 (1%) patients without reconstruction (P \ .01). Additionally, 7 (41%) patients who received bilateral radiation to the neck had G-tube placement, with 3 (18%) requiring chronic G-tube utilization.
Multivariable analysis demonstrated that primary tumors of the oral cavity, pharynx, and larynx; multimodality treatment; and expected surgical parameters independently predicted feeding tube utilization (P \ .01). Table 5 details the multivariable model results.
Discussion
Multimodality management of selected SGMs confers locoregional and distant disease control benefits, but the associated treatment-related toxicities, such as acute mucositis, xerostomia, and chronic swallowing dysfunction. Toxicities can impair recovery and quality of life in cancer survivorship. Feeding tube utilization for nutrition support is well characterized in certain head and neck cancers. However, studies detailing feeding tube utilization in patients with SGMs have not been published. Our investigation presents the first large-sample analysis of feeding tube utilization exclusive to patients with SGM. Feeding tube utilization among all SGM patients was low.
We found that 28% of the cohort needed nutrition support with an NG-tube and that 10% eventually required conversion to a G-tube; however, high-risk groups emerged in subgroup analyses identifying those SGM patients for whom dysphagia prophylaxis is likely warranted. Classifiersincluding minor gland cancer sites arising in the larynx or pharynx and multimodality treatment regimens-were associated with robust effect sizes in multivariate statistical analysis ( Table 5) , asserting their predictive value. As expected, multimodality treatment for SGM (definitive chemoradiotherapy or surgery, followed by adjuvant radiation and/or chemotherapy) was an independent risk factor for G-tube placement and chronic dependence. In contrast, single-modality treatment, which was predominantly surgery alone, did not carry the same risk. Radiation to the bilateral neck, while rare, was associated with increased feeding tube and G-tube usage. These results reiterate the detrimental effects of postoperative radiation to the neck on swallowing function that have been reported in other non-SGM cohorts. [14] [15] [16] [17] Langendijk et al reported bilateral neck irradiation as an independent predictor of swallow dysfunction, 18 and analyses specific to organs at risk correlate average radiation doses of 50 to 70 Gy to dysphagia in the pharyngeal constrictor and laryngeal regions. [19] [20] [21] [22] In addition, these investigators and others-including those of a large multi-institutional review of G-tube usage after nonsurgical therapy for oropharyngeal cancer-found that concurrent chemotherapy is an independent risk factor for longterm G-tube dependence. 10, 23 Our findings corroborate these prior observations, in that multimodality treatment with radiation (ie, surgery with adjuvant radiation or definitive chemoradiation) and neck irradiation fields predispose SGM patients to enteral feeding with greater potential for long-term dependence. 24, 25 Feeding tube utilization was, by far, most common in SGMs arising in pharyngeal and laryngeal sites. This trend was particularly pronounced among patients with pharyngeal or laryngeal salivary malignancies requiring multimodality treatment, among whom 50% required a G-tube and 14% became chronically feeding tube dependent in longterm follow-up. Rates of chronic gastrostomy in this subgroup of SGMs parallel those reported in predominantly squamous cell carcinoma series, as in that by Caudell et al, who reported 14% 2-year G-tube dependence after chemoradiation for head and neck cancer, with base of tongue, hypopharyngeal, and laryngeal cancers at higher risk for persistent dysphagia. 26 Surgical factors had a substantial impact on feeding tube utilization in SGM. When results were stratified by surgical fields, cases with resections within the oral cavity, pharynx, and/or larynx had significantly higher rates of NG-tube (41%-75%) and G-tube usage (14%-25%) than those involving other surgical fields (8% and 5%, respectively). Cases with oral cavity resection fields also included patients with sinonasal tumors, who had the second-highest feeding tube usage rate, as they underwent maxillectomy and/or palatectomy. Small sample size in these subgroups may have limited correlating these surgical parameters with chronic G-tube dependence. Surgery involving the bolus passageway requires substantial physical, mechanical, and sensory adaptation by the patient. The degree of swallowing impairment is further influenced by volume and location of surgical resection in the oral cavity and oropharynx, as others have previously studied in great detail, but these surgical factors were not available in this study. 27 Dysphagia following free flap reconstruction in the oral cavity and oropharynx is a common and well-characterized clinical condition. A prospective case series by McConnel et al demonstrated less efficient swallow function with greater pharyngeal residue and longer dwell times in patients who underwent free flap reconstruction versus primary closure. 28 Our results are consistent with those of McConnel et al and earlier investigations that describe significant incompetency during oral and pharyngeal phases of swallowing after extensive resections necessitating intraoral and pharyngeal free flap surgery. 27, 29, 30 Nearly 40% of patients in our SGM cohort who had extensive surgical resection necessitating free flap reconstruction required G-tube placement, with approximately half of them becoming chronically dependent on G-tube feedings. Free flap reconstruction was an independent risk factor for G-tube utilization in multivariate models adjusted for adjuvant therapy. Low event rates of chronic G-tube dependence precluded multivariate analysis of this end point. Notably, however, none of the patients with flap reconstruction alone became chronically G-tube dependent; all patients who became G-tube dependent after flap reconstruction had also received adjuvant radiotherapy, reiterating multimodality treatment as an independent risk for chronic dependence. By determining subgroups of patients who have higher risk for requiring enteral feeding, clinical decision-making models can be enhanced to help educate patients and anticipate barriers to treatment adherence or recovery. Prior studies on enteral nutrition support in head and neck cancer have predominantly focused on patients treated with definitive radiotherapy for squamous cell carcinomas of the head and neck. Some programs perform prophylactic G-tube placement to prevent weight loss and adjuvant treatment breaks, but prolonged periods without oral intake are also linked with longterm G-tube dependence, dysphagia, and adverse remodeling of swallowing muscles that exacerbate the treatment effects. [31] [32] [33] Our institution adopts a reactive, or ''wait and see,'' approach by closely following a patient's ability to maintain adequate oral intake and weight before recommending enteral feeding routes. The feasibility of this approach has been demonstrated in large published series. 9, 13 The intent of this practice is to minimize swallow deconditioning from prolonged enteral dependence and avoid risks and costs of the procedure when possible, as advocated by previous studies. 9, 13, 34, 35 In our earlier published series, 30% to 40% of patients undergoing chemoradiotherapy for oropharyngeal and hypopharyngeal carcinomas avoided placement of G-tubes, with a lower likelihood of gastrostomy dependence among patients also participating in preventive swallow exercise therapy. 9, 13 Our present analysis argues that high-risk groups of SGM patients-such as those with multimodality treatment, bilateral neck irradiation, SGMs arising in the pharyngeal and laryngeal sites, and those requiring intraoral free flap reconstruction-might benefit from similar proactive swallowing therapy service models in an effort to lower rates of chronic gastrostomy dependence.
Overall, our results demonstrate favorable outcomes with a reactive feeding tube placement approach for patients with SGMs, as evidenced by low rates of reactive NG-tube feeding (28%) and G-tube utilization (10%). As patients with pharyngeal and laryngeal SGMs were at the highest risk for feeding tube utilization and dependence, standardized observation and medical scrutiny are warranted, similar to surveillance models that have been popularized for squamous cell carcinoma of the head and neck. Concomitant with counseling about the probability of requiring a feeding tube, these patients may benefit from a prophylactic swallow therapy program instituted before and after treatment initiation to assist with their ability to continue oral intake safely. Previous investigations by our group have demonstrated that a reactive tube placement model coupled with maintenance of oral intake and swallowing exercises may help prevent placement or shorten gastrostomy duration and maintain more normal diets after treatment. 9, 36 Therefore, a multidisciplinary approach in addressing dysphagia in patients with SGMs who are undergoing adjuvant radiotherapy or definitive chemoradiation might provide improved outcomes in swallowing rehabilitation and need for long-term enteral support.
A significant limitation of this study is its retrospective observational design, which restricts the ability to definitively identify predictors of feeding tube placement and causal inferences. We also acknowledge the potential for internal bias that is inherent to a retrospective singleinstitution analysis such as this, particularly with regard to subjectivity in practice patterns (eg, decisions on feeding tube candidacy). However, this study represents the first detailed analysis of feeding tube utilization in SGMs that may be instrumental to future studies investigating clinical outcomes and quality-of-life implications. A relatively large sample size and prospectively ascertained clinical details enabled analysis of SGM-specific factors associated with G-tube dependence. Future studies prospective in design would provide further insight into G-tube dependence and timing for patients with SGM.
Conclusion
These results demonstrate low incidence of G-tube placement (10%) among all SGM patients in an institution with a reactive tube placement model. G-tube utilization appears exclusive to patients treated with multimodality therapy, and chronic gastrostomy remains high (14%) in patients with minor gland cancers arising in the pharynx and larynx who require multimodality therapy, thus suggesting impetus for dysphagia prophylaxis in these higher-risk patient groups.
